MedCann Industries Inc NSRS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.01
- Market Cap
- $7.83
- Volume/Avg
- 10,000 / 1,785
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
MedCann Industries Inc is focused on the evaluation, acquisition, and development of products and businesses in the mineral resource, pharmaceutical, and medical technology industries. It creates and develops a Distribution, Research, and Manufacturing Facility. It intends to manufacture and assemble Medicine, Cosmetic, Health treatment products, and drinks. Its products include Cannabis Oil.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- 1
Valuation
|
Metric
|
NSRS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
NSRS
|
|---|---|
Quick Ratio | 0.11 |
Current Ratio | 0.11 |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
NSRS
|
|---|---|
Return on Assets (Normalized) | −120.31% |
Return on Equity (Normalized) | −769.37% |
Return on Invested Capital (Normalized) | −153.69% |
Return on Assets
No chart available
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Jhyfkqgmgk | Mvf | $79.4 Bil | |
MKKGY
| Merck KGaA ADR | Cbtlnzdxt | Mlxhft | $79.0 Bil | |
HLN
| Haleon PLC ADR | Wkwqhdvsw | Jbh | $38.5 Bil | |
VTRS
| Viatris Inc | Pxqbybyln | Vwmp | $13.1 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Tyklspmt | Hfq | $11.7 Bil | |
CTLT
| Catalent Inc | Ydvhbbxdw | Zfrwhcq | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Zcspfppp | Yxt | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Zydxpqjj | Tlsk | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Yvlkhggz | Hlmdtr | $3.2 Bil | |
GTBIF
| Green Thumb Industries Inc | Fztllpcvr | Bfxr | $3.1 Bil |